Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Osteoporosis: HELP
Hideaki Sowa
Based on 17 articles published since 2009
(Why 17 articles?)
||||
Expertise Level
The expertise of Hideaki Sowa ranks in the
  • Top 0.64%
  • ... of 58,015 published authors worldwide on Osteoporosis
  • ... from 2009 through 2019
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Sowa, H   ·   Sowa, Hideaki
Work Locations
Details
Most likely:    Miscellaneous cities in Japan      
2015
  • Medical Science, Lilly Research Laboratories, Medicines Development Unit Japan. · Asia Pacific Statistical Science-Japan, Science and Regulatory Affairs, LRL MDU-Japan, Eli Lilly Japan K.K, Kobe, Hyogo, Japan. · Pubmed 26185429
2012
Probable:    Miscellaneous institutions in Kobe      
2015
  • United Osteoporosis Centers, Gainesville, GA, USA. · Osteoporosis Research Center, Creighton University, Omaha, NE, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Fuji Memorial Institute of Medical Sciences, University of Tokushima, Tokushima, Japan. · Lilly Research Laboratories Japan, Kobe, Japan. · Pubmed 25707611
Probable:    Eli Lilly Corporation      
2011
  • Medical Science, Lilly Research Laboratories Japan, Eli Lilly Japan KK. · Pubmed 21187589
2015
  • 1Toranomon Hospital Endocrine Center, Tokyo, Japan 2Medical Science, Medicines Development Unit Japan, Eli Lilly Japan KK, Kobe, Hyogo, Japan 3Asia Pacific Statistical Sciences, Medicines Development Unit Japan, Eli Lilly Japan KK, Kobe, Hyogo, Japan. · Pubmed 25756692
2014
  • Medical Science, Lilly Research Laboratories Development Center of Excellence Japan, Eli Lilly Japan K.K., Sannomiya Plaza Bldg, 7-1-5 Isogamidori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan, · Pubmed 24368586
  • Lilly Research Laboratories Development Center of Excellence Japan Eli Lilly Japan KK Kobe, Japan. · Pubmed 24281238
2013
  • Japan Health Technology Assessment, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 23536192
  • Eli Lilly Japan KK, Sannomiya Plaza Bldg., 7-1-5 Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 23135345
2012
  • Lilly Bio-Medicines, Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 22752125
  • Lilly Research Laboratories-Development Center of Excellence-Asia Pacific, Eli Lilly Japan K.K., Sannomiya Plaza Bldg., 7-1-5 Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 21938381
2011
  • Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5 Isogamidori, Kobe 651-0086, Japan. · Pubmed 21168536
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Hideaki Sowa about Osteoporosis:

  • A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia. 2015
  • Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation. 2015
  • The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density. 2015
  • A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. 2015
  • Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study. 2015
  • Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study. 2015
  • The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim report. 2014
  • Re: Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance. 2014
  • Osteoporosis and treatments in Japan: management for preventing subsequent fractures. 2013
  • Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis. 2013
Show List of Full Article Records
Google Searches

Learn more about Hideaki Sowa using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in Japan
Miscellaneous institutions in Kobe
Eli Lilly Corporation
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in Japan
2015
  • Medical Science, Lilly Research Laboratories, Medicines Development Unit Japan. · Asia Pacific Statistical Science-Japan, Science and Regulatory Affairs, LRL MDU-Japan, Eli Lilly Japan K.K, Kobe, Hyogo, Japan. · Pubmed 26185429
2012
Miscellaneous institutions in Kobe
2015
  • United Osteoporosis Centers, Gainesville, GA, USA. · Osteoporosis Research Center, Creighton University, Omaha, NE, USA. · Eli Lilly and Company, Indianapolis, IN, USA. · Fuji Memorial Institute of Medical Sciences, University of Tokushima, Tokushima, Japan. · Lilly Research Laboratories Japan, Kobe, Japan. · Pubmed 25707611
Eli Lilly Corporation
2011
  • Medical Science, Lilly Research Laboratories Japan, Eli Lilly Japan KK. · Pubmed 21187589
2015
  • 1Toranomon Hospital Endocrine Center, Tokyo, Japan 2Medical Science, Medicines Development Unit Japan, Eli Lilly Japan KK, Kobe, Hyogo, Japan 3Asia Pacific Statistical Sciences, Medicines Development Unit Japan, Eli Lilly Japan KK, Kobe, Hyogo, Japan. · Pubmed 25756692
2014
  • Medical Science, Lilly Research Laboratories Development Center of Excellence Japan, Eli Lilly Japan K.K., Sannomiya Plaza Bldg, 7-1-5 Isogamidori, Chuo-ku, Kobe, Hyogo, 651-0086, Japan, · Pubmed 24368586
  • Lilly Research Laboratories Development Center of Excellence Japan Eli Lilly Japan KK Kobe, Japan. · Pubmed 24281238
2013
  • Japan Health Technology Assessment, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5, Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 23536192
  • Eli Lilly Japan KK, Sannomiya Plaza Bldg., 7-1-5 Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 23135345
2012
  • Lilly Bio-Medicines, Eli Lilly and Company, Indianapolis, IN, USA. · Pubmed 22752125
  • Lilly Research Laboratories-Development Center of Excellence-Asia Pacific, Eli Lilly Japan K.K., Sannomiya Plaza Bldg., 7-1-5 Isogamidori, Chuo-ku, Kobe, 651-0086, Japan. · Pubmed 21938381
2011
  • Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5 Isogamidori, Kobe 651-0086, Japan. · Pubmed 21168536
5 Other Locations Show
Yearly article counts 00006225200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.